Every issue cites the paper.
If a protocol appears in PeptoSfera, it's anchored in peer-reviewed literature. We cite the author, the year, the sample size. You read the sentence and know exactly where it came from.
Every Thursday, one molecule. Decoded with the precision of someone who read the original paper and the clarity of someone who ran the cycle. Doses, stacks, real sources — and the final verdict.
If a protocol appears in PeptoSfera, it's anchored in peer-reviewed literature. We cite the author, the year, the sample size. You read the sentence and know exactly where it came from.
PeptoSfera has no affiliate links, no commission program, and resells no vials. The subscription is the only source of revenue — and that's what keeps the verdict honest.
No "it depends on your case, talk to your doctor." The literature allows an answer — and PeptoSfera picks a side. Yes, conditional, or no. You pay for the position, not the asterisk.
The molecule born in Zagreb that became the silent protocol of Brazilian athletes. Real dose, cycle, trusted sources in São Paulo, and the final verdict.
A real clinical comparison between the two molecules redefining premium Brazilian aesthetics. Titration, profile, compounding costs, and the case where Semaglutide still wins.
What it costs to import, which labs compound it, the controversial "Rapamycin Sunday," and what the 2025 study changed about preventive geriatric dosing.
“Most of what's published about peptides in Brazil is an influencer selling an affiliate link. PeptoSfera was born to be the opposite: someone who reads the papers in English, talks to São Paulo's sports physicians, and tells you — in plain language — what's worth running and what's marketing. No broscience. No affiliates. Just science, decoded every Thursday.”